Monday, June 15, 2020

Cancer: Drug with new approach on impeding DNA repair shows promise in first clinical trial

Berzosertib, an ATR-targeting drug, improves progression-free survival in combination with chemotherapy in patients with high-grade serous ovarian cancer.

from Latest Science News -- ScienceDaily https://ift.tt/3hpjKKi
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Scientists rediscover lost Megalodon fossils—and reveal a 79-foot giant

Several enormous Megalodon vertebrae thought to have been destroyed in 1989 were found sitting unnoticed on a museum shelf. Their analysis s...